Tearing down walls: opening the border between hospital and ambulatory care for quality improvement in Germany by Szecsenyi, Joachim et al.
Tearing down walls: opening the border
between hospital and ambulatory care for
quality improvement in Germany
JOACHIM SZECSENYI1,2, BJOERN BROGE1, JOERG ECKHARDT1, GUENTHER HELLER1,
PETRA KAUFMANN-KOLLE1 AND MICHELWENSING2,3
1AQUA-Institute for Applied Quality Improvement and Research in Healthcare, Goettingen, Germany,
2Department of General Practice
and Health Services Research, University of Heidelberg Hospital, Heidelberg, Germany, and
3Scientiﬁc Institute for Quality of Healthcare,
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Address reprint requests to: Joachim Szecsenyi, AQUA-Institute for Applied Quality Improvement and Research in Healthcare, Goettingen,
Germany. E-mail: joachim.szecsenyi@aqua-institut.de
Accepted for publication 11 December 2011
Abstract
The hospital benchmarking system in Germany was originally introduced to detect unintended consequences of reimburse-
ment based on diagnosis-related groups. The new nationwide SQG programme aims to provide information on quality and
outcomes of health care provided in hospital, ambulatory specialist and primary care settings, including the healthcare delivery
across different sectors. In 2010 the topics for indicator development were cataract surgery, cervical conization, colectoral
cancer and percutaneous coronary interventions or coronary angiography. A systematic stepwise modiﬁed RAND/UCLA
procedure is applied to develop quality indicators in each of these domains. A general framework for data collection is imple-
mented. Benchmarking results are fed back to providers on a regular basis.
Keywords: quality measurement, quality indicators, health policy, hospital care, primary care/general practice, general
medicine, surgery
‘Mr Gorbatschov, tear down this wall’ is a statement of the
former US President Ronald Reagan from his famous public
address in Berlin in 1987. While this became reality in 1989
and the 20th anniversary of Germany’s reuniﬁcation could
be celebrated in 2010, other borders like those between
ambulatory and hospital care proved to be more resistant
than the former ‘iron curtain’. In 2009 the German Federal
Joint Committee established a comprehensive programme
for quality improvement across healthcare sectors in
Germany (‘Sektoru ¨bergreifende Qualita ¨tssicherung im
Gesundheitswesen’ or ‘SQG’). The programme expands the
nationwide system for benchmarking of hospitals, established
in 2001 [1], now aiming at quality improvement in outpatient
as well as inpatient medical care. This implies a major redir-
ection of the German approach to quality improvement. The
SQG programme complements the German Institute for
Quality and Efﬁciency in Health Care, which provides
evidence-based evaluations of health technology since 2004.
The contract for the SQG programme has been gained in an
open competition by the AQUA-institute, a privately owned
research organization located at Goettingen, Germany. The
contractor is the Federal Joint Committee (G-BA), the
highest national body which regulates the healthcare system
independently under the supervision of the Ministry of
Health. The AQUA-institute collaborates intensively with
European academic research centres: the Department of
General Practice and Health Services Research and the
Department of Biostatistics at University Hospital
Heidelberg in Germany and the Scientiﬁc Institute for
Quality in Health Care at Radboud University Medical
Centre Nijmegen in the Netherlands. In this paper we aim to
describe the objectives and content of the SQG programme.
Some short information on the German healthcare system
will be provided ﬁrst as a background.
German healthcare system
Germany has a population of 82 million inhabitants, in
which 20 million (24%) are aged 65 years or over—a propor-
tion that will increase to 33% in 2030 [2]. In 2008 the
country spent 10.5% of its gross domestic product on health
care; this ﬁgure yielded 8.7% in the UK and 16.0% in the
USA in the same year [2]. The expenses are covered by
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and employers. In 2008 Germany had 3.6 practising physi-
cians per 1000 inhabitants, which was higher than England
(2.6) and the USA (2.4) in that year. German citizens have
free choice of both healthcare providers and health insurers,
thus these compete for their share of the market. To
enhance coordination and reduce unnecessary utilization,
small co-payments for patients were introduced for every
quarterly ﬁrst visit of a patient to healthcare providers, stays
in hospitals and prescribed medication.
German health professionals offer a wide range of pre-
ventive, diagnostic and treatment procedures, including
options from complementary medicine. Traditionally, there is
little guidance by evidence-based guidelines in daily clinical
practice, but disease management programmes were intro-
duced in primary care for a number of chronic diseases in
2004 [3]. To deﬁne the framework for the SQG programme
in the German social code book, there is a complete chapter
(§137a SGB V) deﬁning rights and commitments of the
various stakeholders. In the centre of these regulations, the
legislator puts the obligation that the institution which runs
the programme has to fulﬁll its tasks on a sound scientiﬁc
basis and that it should perform its works independently
from stakeholders in the healthcare system, e.g. statutory
sickness funds, private health insurances or healthcare provi-
ders or pharmaceutical industry. The idea behind is to
enhance public trust in the quality monitoring system.
SQG programme’s objectives
The hospital benchmarking system in Germany was originally
introduced to detect unintended consequences of the
‘ﬂat-rate’ payment system of hospitals in 1996. Since 2004, it
aimed to examine the consequences of reimbursement based
on diagnosis-related groups. The new SQG programme is
independent of reimbursement systems and aims to provide
information on quality and outcomes of health care provided
in hospital, ambulatory and primary care settings, including
the healthcare delivery across different sectors. An important
user groups for this information are health professionals and
healthcare organizations. One objective of SQG is to provide
formative feedback to healthcare providers to stimulate them
to improve their performance. Research evidence supports
the idea that clinical audit and feedback can moderately
improve clinical practice [4]. Other user groups are the
German Federal Joint Committee, the federal and regional
governments, regional and national bodies of health profes-
sions and institutions, regional quality ofﬁces and health
insurers. These stakeholders can use the information in
various ways, including the guidance for quality programmes
and health policies, legal action if the patient safety is harmed
and adaptations in the contracts with insures. So far no ﬁnan-
cial incentives have been attached to the SQG quality indica-
tors, which might reﬂect the controversy on this issue in
Germany between providers and some payers. German citi-
zens are also intended users. However, until now the use of
objective quality information for choice between healthcare
providers and treatments by individuals still seems to be
limited in Germany [5].
Methods of indicator development
The methods of the SQG programme have been described
in a detailed document, which is publicly available on the
SQG website (www.sqg.de). Each year the German Federal
Joint Committee decides on the clinical domains or clinical
Table 1 Steps in the development of quality monitoring for
a speciﬁc topic
(1) The Federal Joint Committee deﬁnes a topic for
quality monitoring and improvement, after
consultation with various stakeholders.
(2) The AQUA-institute invites experts and stakeholders
for a scoping workshop to discuss key issues for
indicator development.
(3) The AQUA-institute starts a public procedure to
recruit experts for a panel. Additionally, two patient
representatives are nominated by patient
organizations for the panel. All panel members have
to state their conﬂicts of interest.
(4) A structured search for indicators from agencies
worldwide and systematic literature searches is
performed. Duplicates are deleted from the list of
potential indicators.
(5) After an introductory workshop where panelists are
informed and trained, two panel-rounds each with
written ratings and face-to-face discussions are
performed. This results in the ﬁnal set of indicators.
(6) Instruments for data collection (such as for the
electronic clinical records) for the indicators are
developed and data ﬁelds are described.
(7) A preliminary report which describes the
development process, the set of indicators and the
instruments in detail is sent out to all relevant
stakeholder organizations. These have 6 weeks to
send their comments back.
(8) A ﬁnal report with an appraisal of the comments is
completed by the AQUA-institute within 6 weeks.
(9) The Federal Joint Committee ofﬁcially approves the
ﬁnal report.
(10) The Federal Joint Committee decides whether a
feasibility study and ﬁeld testing is needed.
(11) After ﬁnal positive evaluation, a directive of the
Federal Joint Committee makes quality measurement
and monitoring, mandatory for all health care
providers.
(12) A planning is made and communicated for inclusion
of indicators in data collection and in the annual
reports that are provided by the AQUA-institute.
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instance, in 2010 the topics for indicator development
were cataract surgery, cervical conization, colectoral cancer
and percutaneous coronary interventions or coronary angiog-
raphy. A systematic stepwise procedure is applied to develop
quality indicators in each of these domains. The ﬁrst step of
this procedure is a systematic review of published research of
available indicators, including published lists of indicators
developed by organizations internationally. This is followed
by a modiﬁed RAND/UCLA procedure [6] with a multidis-
ciplinary panel to select indicators from a long list and adapt
them if necessary. The procedure includes three 1–2-day
group meetings and two written rounds. Panel members are
carefully selected after an open call for participants. Each
panel member is obliged to express his or her conﬂict of
interests in a written form.
After the modiﬁed RAND/UCLA procedure has been
ﬁnalized, a preliminary report is sent to a comprehensive list
of organizations, including scientiﬁc associations, patients’
organizations, colleges, provider- and payer organizations
asking for comments and critical reviews within 6 weeks.
These comments are appraised by the AQUA-institute and
implemented in the ﬁnal report. As a result for the 2010
round, the ﬁnal reports proposed (including 2–9 speciﬁc
items each for patient surveys) 10 indicators for cataract
surgery, 24 indicators for cervical conization and 22 indica-
tors for percutaneous coronary interventions or coronary
angiography while the ﬁnal set for colorectal cancer is not
yet determined. The ﬁnal version of the report, together with
all comments and appraisals is published after formal ap-
proval by the Federal Joint Committee on the SQG website.
The report also contains detailed recommendations as to
how data should be collected. Table 1 summarizes the steps
taken in the development of quality indicators.
Methods of indicator implementation
Selected quality indicators are implemented in systems for
data collection, which have to be used by all healthcare provi-
ders in Germany. Currently, data are derived from informa-
tion systems that are used for clinical and administrative
purposes by healthcare providers. In future, administrative
claims data (i.e. to measure mortality) and patient surveys
will be added. The selected data are sent to the
AQUA-institute using data extraction protocols. In a ﬁrst
step completeness and internal validity of the data are
checked, and if necessary sent back to the healthcare pro-
vider in order to complete or correct the data. When the
data are cleaned, they are statistically analysed and processed
in an automatic way to produce reports for various stake-
holders. To ensure that available data from different sources
can be integrated on a unique patient identiﬁer view and that
data protection is strictly minded, a separate trusted centre
makes all patient related information anonymous before it
goes to the AQUA-institute.
A yearly report providing national summary statistics is
available on the SQG website [7]. When a speciﬁc care
provider is below the predeﬁned thresholds which are set up
by national expert committees, a ‘structured dialogue’ is
started by the AQUA-institute or regional quality organiza-
tions. This dialogue aims to identify and remove potential
errors in the data and to stimulate change. If the scores
remain low, targets for improvement are set and plans for
improvement are made with the care providers. Other instru-
ments that will be implemented in the future may include
peer review and quality circles of health professionals.
Discussion
The SQG programme represents a bold initiative of German
health policy-makers to improve the transparency and quality
across healthcare sectors. It is different from many other
systems by its obligatory and nationwide character. For in-
stance, the quality and outcomes framework in England and
Wales is a voluntary system, although non-participation has
negative ﬁnancial consequences, and limited to primary care
only [8]. The Healthcare Effectiveness Data and Information
Set in the USA is also voluntary, mainly focused on health
plans or larger delivery systems and does not measure out-
comes, except intermediate ones [9].
Evaluation and further development of the methods are
explicit components of the SQG programme. The attempt
to build on research evidence has identiﬁed a large number
of gaps in our knowledge of developing and implementing
quality indicators. Research questions concern, for instance,
the methods for identifying existing quality indicators any-
where in the world, to culturally adapt these indicators, the
composition of panels for the Delphi procedures, the adap-
tion of the type of performance feedback to healthcare pro-
viders, the attribution of outcomes to different providers
involved in the whole pathway of care of patients, the factors
associated with variation of indicator scores across patients
and healthcare providers [10] and the management of health-
care providers with exceptionally low scores on quality indi-
cators. If healthcare delivery wants to be evidence based then
quality improvement should also be evidence based and this
initiative aims to achieve that goal.
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